4-(3-Hydroxyazetidin-1-yl)benzoic acid is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of biologically active compounds. Its structure, featuring both a benzoic acid moiety and a hydroxyazetidine ring, makes it a valuable building block for designing drugs targeting various therapeutic areas. It is often employed in the creation of small molecule inhibitors and modulators, particularly for enzymes and receptors involved in inflammation, cancer, and neurological disorders. Additionally, its functional groups allow for further chemical modifications, enabling the development of derivatives with enhanced pharmacological properties. The compound is also explored in medicinal chemistry for its potential to improve drug solubility and bioavailability.